Soltis Investment Advisors’s CME Group CME Stock Holding History

Soltis Investment Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-847	Closed	-$250K	–	661
2026 Q1	$250K	Buy	+847	New	+$252K	0.02%	487

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Soltis Investment Advisors's CME Position: Q2 2026 in Review

Soltis Investment Advisors sold out of CME Group (CME) in Q2 2026, closing a stake of 847 shares — an estimated $250K sold.

Soltis Investment Advisors first reported a position in CME in Q1 2026 and held it in 1 quarter. The position peaked at $250K in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Soltis Investment Advisors reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Soltis Investment Advisors sold 847 CME Group shares in Q2 2026, an estimated $250K.
Soltis Investment Advisors first reported a position in CME Group in Q1 2026 and held it in 1 quarter.
Soltis Investment Advisors's CME Group position peaked at $250K in Q1 2026.
1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.